Skip to content
2000
Volume 21, Issue 4
  • ISSN: 1570-159X
  • E-ISSN: 1875-6190

Abstract

Parkinson’s disease (PD) is one of the most prevalent neurodegenerative disorders, affecting the basal nuclei, causing impairment of motor and cognitive functions. Loss of dopaminergic (DAergic) neurons or their degeneration and the aggregation of Lewy bodies is the hallmark of this disease. The medications used to treat PD relieve the symptoms and maintain quality of life, but currently, there is no cure. There is a need for the development of therapies that can cease or perhaps reverse neurodegeneration effectively. With the rapid advancements in cell replacement therapy techniques, medical professionals are trying to find a cure by which restoration of dopamine neurotransmitters can occur. Researchers have started focusing on cell-based therapies using mesenchymal stem cells (MSCs) due to their abundance in the body, the ability of proliferation, and immunomodulation. Here we review the MSC-based treatment in Parkinson's disease and the various mechanisms it repairs DAergic neurons in parkinsonian patients.

Loading

Article metrics loading...

/content/journals/cn/10.2174/1570159X20666220327212414
2023-04-01
2024-11-23
Loading full text...

Full text loading...

/content/journals/cn/10.2174/1570159X20666220327212414
Loading

  • Article Type:
    Research Article
Keyword(s): dopaminergic neurons; mesenchymal stem cells; Parkinson’s disease; stem cell; therapy
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test